CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo.

Koch M, Hussein F, Woeste A, Gründker C, Frontzek K, Emons G, Hawighorst T

Open source

DOI
10.1007/s10549-010-1085-7
Published
2011 Jul
Container
Breast cancer research and treatment
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10549-010-1085-7,
  title = {CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo.},
  author = {Koch M and Hussein F and Woeste A and Gründker C and Frontzek K and Emons G and Hawighorst T},
  year = {2011},
  journal = {Breast cancer research and treatment},
  doi = {10.1007/s10549-010-1085-7},
  url = {https://doi.org/10.1007/s10549-010-1085-7}
}

RIS

TY  - JOUR
TI  - CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo.
AU  - Koch M
AU  - Hussein F
AU  - Woeste A
AU  - Gründker C
AU  - Frontzek K
AU  - Emons G
AU  - Hawighorst T
PY  - 2011
JO  - Breast cancer research and treatment
DO  - 10.1007/s10549-010-1085-7
UR  - https://doi.org/10.1007/s10549-010-1085-7
ER  - 

APA

M, K., F, H., A, W., C, G., K, F., G, E., & T, H. (2011). CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo.. Breast cancer research and treatment. https://doi.org/10.1007/s10549-010-1085-7

Source records